Rapid diagnostic HCV antibody assays

Details

• Alternative Title:
  Antivir Ther
• Personal Author:
  Smith, Bryce D ; Jewett, Amy ; Drobeniuc, Jan ; Kamili, Saleem
• Description:
  Approximately 4.1 million Americans have been infected with HCV and 45-85% of chronically infected persons are unaware of their status. Rapid anti-HCV assays can assist and expedite the identification of those unaware of their infection. Performance characteristics of pre-market rapid anti-HCV assays (Chembio, MedMira and OraSure) have been evaluated. Their sensitivity (78.9-99.3%) and specificity (80-100%) varied. Future investigations could include evaluation of rapid anti-HCV tests in persons who are coinfected with HCV and HIV, and development of rapid HCV-antigen tests and nucleic acid tests.
• Subjects:
  Hepacivirus Hepatitis C Hepatitis C Antibodies Hepatitis C Antigens Humans Reagent Kits, Diagnostic Sensitivity And Specificity Time Factors
• Source:
  Antivir Ther. 17(7 Pt B):1409-1413.
• Pubmed ID:
  23322678
• Pubmed Central ID:
  PMC5791540
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHS/United States
• Place as Subject:
  United States
• Volume:
  17
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:900631ef87c817c7b399d10669ce450f33df165c72878634402eddb33d5ed632
• Download URL:
  https://stacks.cdc.gov/view/cdc/51294/cdc_51294_DS1.pdf
• File Type:
  [PDF - 57.88 KB ]